| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737159.2015.1069709 |
| P698 | PubMed publication ID | 26189641 |
| P2093 | author name string | Michael J Heller | |
| Jean M Lewis | |||
| Daniel P Heineck | |||
| P2860 | cites work | High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. | Q54648888 |
| Fetal DNA detection in maternal plasma throughout gestation | Q56836344 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey | Q57417360 | ||
| Lung-protective ventilation suppresses plasma levels of cell-free DNA in porcine experimental postoperative sepsis | Q59322759 | ||
| Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer | Q24604601 | ||
| miR-221 overexpression contributes to liver tumorigenesis | Q24646374 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression | Q24653755 | ||
| Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma | Q27324064 | ||
| Dielectrophoretic isolation and detection of cancer-related circulating cell-free DNA biomarkers from blood and plasma | Q42969236 | ||
| The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus | Q44393152 | ||
| Prognostic value of cell-free DNA in plasma of out-of-hospital cardiac arrest survivors at ICU admission and 24h post-admission | Q45168070 | ||
| Alternating current electrokinetic separation and detection of DNA nanoparticles in high-conductance solutions | Q46226870 | ||
| Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma | Q46231098 | ||
| Dielectrophoretic isolation of DNA and nanoparticles from blood | Q46253281 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| Cell-free DNA in maternal plasma: is it all a question of size? | Q47313732 | ||
| Circulating mitochondrial DNA in serum of patients with granulomatosis with polyangiitis | Q48215573 | ||
| Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury | Q48405515 | ||
| Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker? | Q50472491 | ||
| Continuous-flow sorting of stem cells and differentiation products based on dielectrophoresis. | Q51501202 | ||
| Methods for isolation of cell-free plasma DNA strongly affect DNA yield. | Q52893352 | ||
| Neutrophils release extracellular DNA traps in response to exercise. | Q53050483 | ||
| Exercise is a potent stimulus for enhancing circulating DNase activity. | Q53075964 | ||
| Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients. | Q54171423 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma | Q28118099 | ||
| Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
| Circulating mutant DNA to assess tumor dynamics | Q28289337 | ||
| Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield | Q28744238 | ||
| Analysis of circulating tumor DNA to monitor metastatic breast cancer | Q29614797 | ||
| Detection of circulating tumor DNA in early- and late-stage human malignancies | Q29615778 | ||
| Review article-dielectrophoresis: status of the theory, technology, and applications | Q30480055 | ||
| An AC electrokinetic method for enhanced detection of DNA nanoparticles | Q33430298 | ||
| An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. | Q33590850 | ||
| Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care | Q33793544 | ||
| The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? | Q33858586 | ||
| siRNA-like double-stranded RNAs are specifically protected against degradation in human cell extract | Q33925270 | ||
| Increased plasma cell-free DNA level during HTNV infection: correlation with disease severity and virus load | Q33963432 | ||
| Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood | Q33965667 | ||
| DNA damage modulates interactions between microRNAs and the 26S proteasome | Q33976943 | ||
| Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes | Q34040540 | ||
| Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation | Q34061842 | ||
| About the possible origin and mechanism of circulating DNA apoptosis and active DNA release | Q34100424 | ||
| Detection and quantification of mutations in the plasma of patients with colorectal tumors | Q34132363 | ||
| Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology | Q34165070 | ||
| Trapping of DNA in nonuniform oscillating electric fields | Q34180007 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| Isolation and characterization of DNA from the plasma of cancer patients | Q34186554 | ||
| Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury | Q34224506 | ||
| Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification | Q34277946 | ||
| Characterization of microfluidic shear-dependent epithelial cell adhesion molecule immunocapture and enrichment of pancreatic cancer cells from blood cells with dielectrophoresis | Q34304356 | ||
| A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. | Q34351104 | ||
| Dielectrophoresis for bioparticle manipulation | Q34486801 | ||
| Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer. | Q34796583 | ||
| Akonni TruTip(®) and Qiagen(®) methods for extraction of fetal circulating DNA--evaluation by real-time and digital PCR. | Q34927319 | ||
| Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients | Q34999508 | ||
| Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD | Q35034936 | ||
| Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery. | Q35069863 | ||
| Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. | Q35078413 | ||
| High cell-free DNA predicts fatal outcome among Staphylococcus aureus bacteraemia patients with intensive care unit treatment | Q35092654 | ||
| Regulation of MicroRNA Biogenesis: A miRiad of mechanisms | Q35575239 | ||
| ApoStream(™), a new dielectrophoretic device for antibody independent isolation and recovery of viable cancer cells from blood | Q36094784 | ||
| MicroRNAs in body fluids--the mix of hormones and biomarkers | Q36176435 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Circulating nucleic acids (CNAs) and cancer--a survey | Q36669780 | ||
| Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance | Q36719984 | ||
| Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls | Q37164447 | ||
| The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients | Q37225239 | ||
| Isolation of circulating tumor cells by dielectrophoresis | Q37693324 | ||
| The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries | Q37724919 | ||
| Circulating tumor cells and circulating tumor DNA. | Q37952771 | ||
| Lipid-based carriers of microRNAs and intercellular communication | Q37993698 | ||
| Insights into the potential use of microRNAs as biomarker in cancer | Q38036012 | ||
| Exosomes in tumor microenvironment influence cancer progression and metastasis | Q38091978 | ||
| Circulating cell free DNA: Preanalytical considerations | Q38111116 | ||
| Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis | Q38124901 | ||
| Cell-free nucleic acids as a non-invasive route for investigating atherosclerosis | Q38169740 | ||
| Clinical relevance of circulating cell-free microRNAs in cancer | Q38184908 | ||
| Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids | Q38201710 | ||
| Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. | Q38390966 | ||
| MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells. | Q39041381 | ||
| Extracellular RNA liberates tumor necrosis factor-α to promote tumor cell trafficking and progression | Q39138589 | ||
| Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay | Q39162225 | ||
| Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure | Q39223911 | ||
| miR-205 regulates basement membrane deposition in human prostate: implications for cancer development | Q39354108 | ||
| Dynamic physical properties of dissociated tumor cells revealed by dielectrophoretic field-flow fractionation | Q39520919 | ||
| MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells | Q39870137 | ||
| Noninvasive detection of HER2 amplification with plasma DNA digital PCR. | Q40108755 | ||
| Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation | Q40165772 | ||
| Cell-free DNA is released from tumor cells upon cell death: a study of tissue cultures of tumor cell lines. | Q40642671 | ||
| Dielectrophoretic cell separation and gene expression profiling on microelectronic chip arrays | Q40715625 | ||
| Isolation of cultured cervical carcinoma cells mixed with peripheral blood cells on a bioelectronic chip | Q41034904 | ||
| Quantification of BCR-ABL mRNA in plasma/serum of patients with chronic myelogenous leukemia | Q41137638 | ||
| Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid. | Q41705419 | ||
| Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Q41875540 | ||
| Interaction of Nanoparticles at the DEP Microelectrode Interface under High Conductance Conditions | Q42037416 | ||
| The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels | Q42068501 | ||
| Dielectrophoretic isolation and detection of cfc-DNA nanoparticulate biomarkers and virus from blood | Q42398649 | ||
| P433 | issue | 9 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 1187-1200 | |
| P577 | publication date | 2015-07-18 | |
| P1433 | published in | Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare | Q15756305 |
| P1476 | title | Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids | |
| P478 | volume | 15 |
| Q47250358 | Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles |
| Q50087962 | Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: A study of non-invasive biomarker from Northeast India |
| Q90335185 | Comparative Study of DNA Circuit System-Based Proportional and Exponential Amplification Strategies for Enzyme-Free and Rapid Detection of miRNA at Room Temperature |
| Q37732473 | Dielectrophoresis for Biomedical Sciences Applications: A Review |
| Q38731478 | Electrokinetic device design and constraints for use in high conductance solutions. |
| Q90682389 | Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives |
| Q35901823 | Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes |
| Q39045171 | Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes. |
| Q47614250 | Issues in biomarker identification, validation and development for disease diagnostics in Public Health. |
| Q37290463 | Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma |
| Q37665569 | Simple and robust diagnosis of early, small and AFP-negative primary hepatic carcinomas: an integrative approach of serum fluorescence and conventional blood tests |
| Q58788640 | The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy |
| Q49957946 | The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients |
Search more.